A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy
Arryn Craney, Floyd E Romesberg

Abstract

Antibiotic-resistant bacteria are a significant public health concern and motivate efforts to develop new classes of antibiotics. One such class of antibiotics is the arylomycins, which target type I signal peptidase (SPase), the enzyme responsible for the release of secreted proteins from their N-terminal leader sequences. Despite the essentiality, conservation, and relative accessibility of SPase, the activity of the arylomycins is limited against some bacteria, including the important human pathogen Staphylococcus aureus. To understand the origins of the limited activity against S. aureus, we characterized the susceptibility of a panel of strains to two arylomycin derivatives, arylomycin A-C16 and its more potent analog arylomycin M131. We observed a wide range of susceptibilities to the two arylomycins and found that resistant strains were sensitized by cotreatment with tunicamycin, which inhibits the first step of wall teichoic acid synthesis. To further understand how S. aureus responds to the arylomycins, we profiled the transcriptional response of S. aureus NCTC 8325 to growth-inhibitory concentrations of arylomycin M131 and found that it upregulates the cell wall stress stimulon (CWSS) and an operon consisting of a put...Continue Reading

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Nov 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·W Keller, R Crouch
Mar 1, 1974·Journal of Bacteriology·R E Bryant, P S Sypherd
Jan 1, 1984·Annual Review of Biochemistry·M NomuraG Baughman
Nov 5, 1997·Journal of Molecular Biology·R JanaM C Mossing
Jan 11, 2000·Clinical Microbiology Reviews·M M DingesP M Schlievert
Dec 12, 2002·Chemical Reviews·Mark PaetzelRoss E Dalbey
Aug 9, 2003·Nucleic Acids Research·Christian Toft MadsenStephen Douthwaite
Jun 3, 2004·The Journal of Biological Chemistry·Palaniappan KulanthaivelSheng-Bin Peng
Apr 28, 2005·Applied Microbiology and Biotechnology·Hanne-Leena HyyryläinenVesa P Kontinen
Sep 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·M J J B SibbaldJ M van Dijl
Dec 13, 2006·Nature Reviews. Drug Discovery·David J PayneDavid L Pompliano
Aug 7, 2007·Biochemistry·Sharyn L Rusch, Debra A Kendall
Dec 7, 2007·Journal of the American Chemical Society·Tucker C RobertsFloyd E Romesberg
Dec 15, 2007·Annual Review of Biochemistry·Arnold J M Driessen, Nico Nouwen
May 10, 2008·Molecular Microbiology·Biswajoy Roy-ChaudhuriGloria M Culver
Aug 31, 2010·Biochimica Et Biophysica Acta·David J F du PlessisArnold J M Driessen
Nov 16, 2010·Journal of Bacteriology·Michael E PowersFloyd E Romesberg
Mar 23, 2011·Journal of Bacteriology·Dev K RanjitKenneth W Bayles
May 7, 2011·Journal of Natural Products·Tucker C RobertsFloyd E Romesberg
Jun 3, 2011·Journal of Medicinal Chemistry·Tucker C RobertsFloyd E Romesberg
Jul 26, 2011·Journal of Bacteriology·Mirka E WörmannAngelika Gründling
Mar 27, 2012·Journal of Bacteriology·Mark A SchallenbergerFloyd E Romesberg
Jun 20, 2012·Antimicrobial Agents and Chemotherapy·Alex G TherienLynn Miesel
Oct 17, 2012·Antimicrobial Agents and Chemotherapy·Susan Boyle-VavraRobert S Daum
Oct 25, 2012·Mobile Genetic Elements·Timothy C MeredithTerry Roemer

❮ Previous
Next ❯

Citations

Aug 16, 2015·Bioorganic & Medicinal Chemistry Letters·Arryn Craney, Floyd E Romesberg
Jul 4, 2019·Microbiology Spectrum·Olaf Schneewind, Dominique M Missiakas
Jul 3, 2020·Journal of Natural Products·Yun Xuan TanFloyd E Romesberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.